The Rise of Subscription-Based Content: What It Means for Marketers https://pharma-contractor-manufacturer.mystrikingly.com/blog/the-rise-of-biologics-and-biosimilars-what-it-means-for-patients-and-pharma

Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031. As such, oral solid dose (OSD) formulations are poised to gain significant traction. This shift demands manufacturing partners with proven expertise in: 💊Specialized potent compound handling ⏳ Modified release technology 🎯 Precise quality control systems 📈 Continuity of supply https://www.lannettcdmo.com/advanced-formulation-analytical-services